Search
forResearch 10 of 1000+
- GH-IGF-I axis in non-obese women with functional hyperandrogenism
- Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
- Human Hair Follicles Operate a Functional Peripheral Equivalent of the Hypothalamic-Pituitary-Somatotropic Axis Ex Vivo
- 562 Neuroendocrinology of human scalp hair follicles: Growth hormone-releasing hormone (GHRH) stimulates hair growth and controls a fully functional intrafollicular hypothalamic-pituitary-somatotropic (HPS) signaling axis
- An endocrinopathy characterized by dysfunction of the pituitary-adrenal axis and alopecia universalis: supporting the entity of a triple H syndrome
- Cantú syndrome with coexisting familial pituitary adenoma
- Female Gonadal Function before and after Treatment of Acromegaly
- The effects of oestrogens on linear bone growth
- The pediatric origins of polycystic ovary syndrome
- Normal Pubertal Development: Part I: The Endocrine Basis of Puberty
Community 2 of 5
- Increasing GH and IGF-1 for Increased Growth/Reduced Hair Loss?
- GH peptides + KLOW blend saved my hair. before and after pics.
Learn
— no results
Try a deeper search in learn →